Combination therapy with terbinafine and amphotericin B in a rabbit model of experimental invasive aspergillosisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52005-11-0120OAAI
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patientsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52001-10-01455OAAI
Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52000-10-0173OAAI
Efficacy of SCH56592 in a rabbit model of invasive aspergillosisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52000-03-0156OAAI
Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancerJOURNAL OF CLINICAL MICROBIOLOGYIF5.41999-12-01161OA
Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patientsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.51999-07-0188OAAI
Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.51998-11-01198OAAI
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolatesJOURNAL OF CLINICAL MICROBIOLOGYIF5.41998-10-01165OA
Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformansJOURNAL OF CLINICAL MICROBIOLOGYIF5.41998-05-0124OA
Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patientsCLINICAL INFECTIOUS DISEASESIF7.31998-04-0152OAAI
Interpretation of trailing endpoints in antifungal susceptibility testing by the national committee for clinical laboratory standards methodJOURNAL OF CLINICAL MICROBIOLOGYIF5.41998-01-0199OA
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向